文献速递脊柱外科

大麻使用对腰椎融合术的影响

The Effects of Marijuana Use on Lumbar Spinal Fusion.
PubMed 文献 · Spine (Phila Pa 1976) · 2020-01-01

本研究为回顾性队列研究,比较使用与不使用大麻的患者接受经椎间孔腰椎椎间融合术(TLIF)后的临床与患者报告结局。结果显示,使用大麻者更年轻(P<0.001),但两组在Oswestry功能障碍指数(ODI)评分、融合率及并发症等方面均无显著差异。使用大麻组住院时间更短(2.42 vs. 3.00天,P=0.020)。

要点

  • 使用大麻的TLIF患者更年轻(P<0.001),但性别和BMI无差异。
  • 使用大麻组住院时间更短(2.42 vs. 3.00天,P=0.020)。
  • 两组12个月融合率(96% vs. 92.3%,P=0.678)及ODI在各时间点均无显著差异。

核心结论

  • 接受TLIF的患者无论是否使用大麻,其围手术期结局相似。

主要发现

  • 使用大麻与更年轻的人群相关(P<0.001),但性别和体重指数与不使用组无差异。
  • 两组在并发症、重返手术室或翻修手术方面无统计学显著差异。
  • 多变量分析控制年龄和术前ODI等因素后,使用大麻并未限制术后ODI的改善。
  • 使用大麻组住院时间更短(2.42 vs. 3.00天,P=0.020)。
  • 12个月融合率两组相似(96% vs. 92.3%,P=0.678),ODI在所有时间点组间相似。

关键数值与推荐

  • 住院时间:使用大麻组2.42天 vs. 非使用组3.00天,P=0.020。
  • 12个月融合率:使用大麻组96% vs. 非使用组92.3%,P=0.678。
  • 年龄差异P<0.001;并发症、重返手术室、翻修手术无统计学显著差异。

临床怎么用

  • 对于接受TLIF的患者,术前使用大麻可能不应被视为融合或围手术期结局的禁忌因素。
  • 使用大麻的患者可能住院时间更短,但需结合其他因素综合评估。

局限性

  • 大麻使用基于患者自我报告,可能存在分类偏倚。
  • 证据等级为3级(回顾性队列研究)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: MINI: This study compared clinical and patient-reported outcomes following transforaminal lumbar interbody fusion between patients who use or do not use marijuana. We found that patients who use marijuana are younger, but do not demonstrate any differences in preoperative or postoperative Oswestry disability index scores or rates of fusion. STUDY DESIGN: A retrospective cohort study. OBJECTIVE: The purpose of this study was to evaluate marijuana usage and its effect on outcomes following transforaminal lumbar interbody fusion (TLIF). SUMMARY OF BACKGROUND DATA: As marijuana becomes legalized throughout the United States, its medicinal and recreational usage is becoming more mainstream. Clinicians currently have little guidance regarding both short-term and long-term effects of marijuana usage on surgical interventions. While the rate of lumbar spinal fusion in the United States continues to grow, the effect of marijuana usage on fusion remains uncertain. METHODS: One hundred two patients who underwent TLIF performed by the same surgeon were followed for 12 months. Patients were self-reported for marijuana usage (n = 36). Patient reported outcome measures included preoperative Oswestry disability index (ODI), 6-month ODI, and 12-month ODI, as well as length of stay (LOS), complications, return to operating room (OR), revision surgery, and confirmed fusion. Continuous variables were compared using the independent two-sample t test or analysis of variance (ANOVA), whereas categorical variables were analyzed using the chi-square or Fischer exact tests. Adjusted analysis was performed using a multivariate logistic regression model. RESULTS: Marijuana usage was associated with a younger population (P < 0.001), but showed no difference regarding sex or body mass index compared with the non-usage group. There was no statistically significant difference in complications, return to OR, or revision surgery between groups. When controlling for factors such as age and preoperative ODI, multivariate analysis demonstrated that marijuana usage did not limit postoperative ODI reduction. The marijuana usage group demonstrated shorter LOS (2.42 vs. 3.00 d, P = 0.020). Fusion rates at 12 months were similar between groups (96% vs. 92.3%, P = 0.678). ODI was similar between groups at all time points. CONCLUSION: Perioperative outcomes were similar in patients who underwent TLIF regardless of marijuana usage. LEVEL OF EVIDENCE: 3. A retrospective cohort study. The purpose of this study was to evaluate marijuana usage and its effect on outcomes following transforaminal lumbar interbody fusion (TLIF). As marijuana becomes legalized throughout the United States, its medicinal and recreational usage is becoming more mainstream. Clinicians currently have little guidance regarding both short-term and long-term effects of marijuana usage on surgical interventions. While the rate of lumbar spinal fusion in the United States continues to grow, the effect of marijuana usage on fusion remains uncertain. One hundred two patients who underwent TLIF performed by the same surgeon were followed for 12 months. Patients were self-reported for marijuana usage (n = 36). Patient reported outcome measures included preoperative Oswestry disability index (ODI), 6-month ODI, and 12-month ODI, as well as length of stay (LOS), complications, return to operating room (OR), revision surgery, and confirmed fusion. Continuous variables were compared using the independent two-sample t test or analysis of variance (ANOVA), whereas categorical variables were analyzed using the chi-square or Fischer exact tests. Adjusted analysis was performed using a multivariate logistic regression model. Marijuana usage was associated with a younger population (P < 0.001), but showed no difference regarding sex or body mass index compared with the non-usage group. There was no statistically significant difference in complications, return to OR, or revision surgery between groups. When controlling for factors such as age and preoperative ODI, multivariate analysis demonstrated that marijuana usage did not limit postoperative ODI reduction. The marijuana usage group demonstrated shorter LOS (2.42 vs. 3.00 d, P = 0.020). Fusion rates at 12 months were similar between groups (96% vs. 92.3%, P = 0.678). ODI was similar between groups at all time points. Perioperative outcomes were similar in patients who underwent TLIF regardless of marijuana usage. Level of Evidence: 3.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Jakoi AM, Kirchner GJ, Kerbel YE, et al. The Effects of Marijuana Use on Lumbar Spinal Fusion. Spine (Phila Pa 1976). 2020. PMID: 31770339. doi:10.1097/BRS.0000000000003321

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。